Skip to main content

Study M1039

Study name

Gong WX 2023

Title

Hepatic metabolomics combined with network pharmacology to reveal the correlation between the anti-depression effect and nourishing blood effect of Angelicae Sinensis Radix

Overall design

In this study, hepatic metabolomics and network pharmacology were combined to explore the underlying antidepressive mechanisms of Angelicae Sinensis Radix in the chronic unpredictable mild stress (CUMS) model of depression. Sprague-Dawley rats were divided into the following 5 groups (n = 10 in each group): (1) control group, (2) CUMS group, (3) CUMS + venlafaxine group (stressor plus venlafaxine treatment), (4) CUMS + low dose of Angelicae Sinensis Radix group (stressor plus Angelicae Sinensis Radix treatment at the dose of 3.6 g/kg), and (5) CUMS + high dose of Angelicae Sinensis Radix group (stressor plus Angelicae Sinensis Radix treatment at the dose of 7.2 g/kg). After treatment for 28 days, liver samples were used for metabonomic analysis.

Study Type

Type1;

Type2;

Data available

Unavailable

Organism

Rat; Sprague-Dawley rat;

Categories of depression

Animal model; Chronic mild stress model; Chronic mild stress model;

Criteria for depression

Not reported

Sample size

50

Tissue

Peripheral; Liver; Liver;

Platform

MS-based; LC-MS: Dionex UltiMate 3000 UHPLC system with Q Exactive Orbitrap-MS spectrometer (Thermo Fisher Scientific Inc.,Waltham, Ma, USA);

PMID

37003642

DOI

10.1016/S1875-5364(23)60421-2

Citation

Gong W, Xu S, Song Y, et al. Hepatic metabolomics combined with network pharmacology to reveal the correlation between the anti-depression effect and nourishing blood effect of Angelicae Sinensis Radix. Chin J Nat Med. 2023 Mar;21(3):197-213.

Metabolite

Citric acid;

Pyroglutamic acid;

L-Tryptophan;

L-Proline;

L-Glutamic acid;

L-Lysine;

L-Tyrosine;

Phytosphingosine;

Hypoxanthine;

Taurine;

Niacinamide;

Gluconic acid;

Ornithine;

L-Malic acid;

Adenosine;

Oxidized glutathione;

Glycocholic acid;

Taurochenodesoxycholic acid;

SM(d18:1/16:0);

Cer(d18:1/16:0);

LysoPC(18:2(9Z,12Z));

Sphinganine;

LysoPE(16:0/0:0);

PC(18:0/20:4(5Z,8Z,11Z,14Z));

4-Oxoproline;

Ergothioneine;

Erucamide;

Platelet-activating factor;

PC(18:3(9Z,12Z,15Z)/18:2(9Z,12Z));

5-Methyltetrahydrofolic acid;